Endotoxin administration increases hypothalamic somatostatin mRNA through nitric oxide release

[1]  I. I. de Caceres,et al.  The Inhibition of Inducible Nitric Oxide Synthase Reverts Arthritic‐Induced Decrease in Pituitary Growth Hormone mRNA But Not in Liver Insulin‐Like Growth Factor I mRNA Expression , 2003, Journal of neuroendocrinology.

[2]  I. Ibáñez de Cáceres,et al.  Endotoxin at low doses stimulates pituitary GH whereas it decreases IGF-I and IGF-binding protein-3 in rats. , 2003, The Journal of endocrinology.

[3]  G. Pelletier,et al.  Central nitric oxide regulation of the hypothalamic-pituitary-adrenocortical axis in adult male rats. , 2002, Brain research. Molecular brain research.

[4]  Xue-qun Chen,et al.  Increased somatostatin mRNA expression in periventricular nucleus of rat hypothalamus during hypoxia , 2002, Regulatory Peptides.

[5]  I. Ibáñez de Cáceres,et al.  Glucocorticoids are not necessary for the inhibitory effect of endotoxic shock on serum IGF-I and hepatic IGF-I mRNA. , 2002, The Journal of endocrinology.

[6]  F. Casanueva,et al.  Involvement of Nitric Oxide in the Regulation of Growth Hormone Secretion in Dogs , 2001, Neuroendocrinology.

[7]  D. Feinstein,et al.  Expression and function of inducible nitric oxide synthase in neurons , 2001, Journal of Neuroimmunology.

[8]  S. Arancibia,et al.  Rapid reduction in somatostatin mRNA expression by hypothalamic neurons induced by dexamethasone , 2000, Neuroreport.

[9]  Xue-qun Chen,et al.  Hypoxia influences somatostatin release in rats , 2000, Neuroscience Letters.

[10]  H. Ruan,et al.  [Ketamine and L-NAME inhibit NOS and somatostatin mRNA expression induced by altitude hypoxia in the rat hypothalamus]. , 2000, Sheng li xue bao : [Acta physiologica Sinica].

[11]  A. López-Calderón,et al.  Chronic inflammation inhibits GH secretion and alters the serum insulin-like growth factor system in rats. , 1999, Life sciences.

[12]  J. Bugajski,et al.  Blockade of nitric oxide formation impairs adrenergic-induced ACTH and corticosterone secretion. , 1999, Journal of Physiology and Pharmacology.

[13]  E. Vara,et al.  Effects of endotoxin lipopolysaccharide administration on the somatotropic axis. , 1998, The Journal of endocrinology.

[14]  A. Grossman,et al.  Endotoxin Induces Interleukin-1β and Nitric Oxide Synthase mRNA in Rat Hypothalamus and Pituitary , 1998, Neuroendocrinology.

[15]  K. Lam,et al.  Gene expression of hypothalamic somatostatin and growth hormone-releasing hormone in dexamethasone-treated rats. , 1997, Neuroendocrinology.

[16]  C. Szabó.  Physiological and pathophysiological roles of nitric oxide in the central nervous system , 1996, Brain Research Bulletin.

[17]  C. Diéguez,et al.  Regulation of hypothalamic somatostatin, growth hormone-releasing hormone, and growth hormone receptor messenger ribonucleic acid by glucocorticoids. , 1996, Endocrinology.

[18]  M. Giordano,et al.  Short and long restraint differentially affect humoral and cellular immune functions. , 1996, Life sciences.

[19]  M. Tena-Sempere,et al.  Involvement of endogneous nitric oxide in the control of pituitary responsiveness to different elicitors of growth hormone release in prepubertal rats. , 1996, Neuroendocrinology.

[20]  R. Brogan,et al.  Immunocytochemical and molecular analysis of the effects of glucocorticoid treatment on the hypothalamic-somatotropic axis in the rat. , 1996, Neuroendocrinology.

[21]  J. Geffner,et al.  Nitric oxide synthase inhibitors enhance plasma levels of corticosterone and ACTH. , 1996, Acta physiologica Scandinavica.

[22]  Judith N. Peisen,et al.  Endotoxin-induced suppression of the somatotropic axis is mediated by interleukin-1 beta and corticotropin-releasing factor in the juvenile rat. , 1995, Endocrinology.

[23]  V. Rettori,et al.  Role of nitric oxide in control of growth hormone release in the rat. , 1994, Neuroimmunomodulation.

[24]  M. Aguila.  Growth hormone-releasing factor increases somatostatin release and mRNA levels in the rat periventricular nucleus via nitric oxide by activation of guanylate cyclase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[25]  L. Chung,et al.  Dexamethasone decreases somatostatin mRNA levels in the periventricular nucleus of the rat hypothalamus. , 1993, Neuroendocrinology.

[26]  T. Ishizuka,et al.  Increased hypothalamic somatostatin mRNA following dexamethasone administration in rats. , 1992, Acta endocrinologica.

[27]  Solomon H. Snyder,et al.  Nitric oxide, a novel neuronal messenger , 1992, Neuron.

[28]  K. Fuxe,et al.  Central peptidergic neurons as targets for glucocorticoid action. Evidence for the presence of glucocorticoid receptor immunoreactivity in various types of classes of peptidergic neurons , 1991, The Journal of Steroid Biochemistry and Molecular Biology.

[29]  C. L. Chen,et al.  Influence of chronic restraint stress on pro-opiomelanocortin mRNA and beta-endorphin in the rat hypothalamus. , 1991, Journal of molecular endocrinology.

[30]  S. Hisano,et al.  Existence of mutual synaptic relations between corticotropin-releasing factor-containing and somatostatin-containing neurons in the rat hypothalamus , 1991, Brain Research.

[31]  D. Aron,et al.  Rat pre-prosomatostatin. Structure and processing by microsomal membranes. , 1983, The Journal of biological chemistry.

[32]  N. Kasting,et al.  Altered release of growth hormone and thyrotropin induced by endotoxin in the rat. , 1982, The American journal of physiology.

[33]  I. Ibáñez de Cáceres,et al.  NO plays a role in LPS-induced decreases in circulating IGF-I and IGFBP-3 and their gene expression in the liver. , 2004, American journal of physiology. Endocrinology and metabolism.

[34]  F. Sánchez‐Franco,et al.  Corticosterone modulates growth hormone-releasing factor and somatostatin in fetal rat hypothalamic cultures. , 1995, Neuroendocrinology.

[35]  A. Armario,et al.  Role of somatostatin in the acute immobilization stress-induced GH decrease in rat. , 1993, Life sciences.